Quick Summary
Hertab 250mg Tablet 150's
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹19500
MRP: ₹30975
(You Save ₹11475)
150 TABLET(s) IN A BOTTLE
37% OFF
₹19500
MRP: ₹30,975.00
Inclusive of all taxes
37% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Lapakast 250mg Tablet
APRAZER HEALTHC...
₹ 91.50/tablet
29% cheaper
Lapibuzz 250mg Tablet
JASGUR LIFE SCI...
₹ 99.60/tablet
23% cheaper
Lapagis 250mg Tablet
AEGIS PHARMACEU...
₹ 108.17/tablet
16% cheaper
Lapalieva 250mg Tablet
Allieva Pharma ...
₹ 108.33/tablet
16% cheaper
Introduction to Hertab 250mg Tablet 150's
Hertab Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer, and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor -2.
The common side effects that are likely to occur while you are on the treatment with Hertab Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.
Inform your healthcare provider when you notice any signs of diarrhea or dehydration. Monitor your blood pressure regularly while taking this medication. If you have diarrhoea while taking this medication, drink plenty of fluids, eat low-fat, high-protein foods, and avoid milk and its products and herbal supplements.
Uses of Hertab 250mg Tablet 150's
Treats advanced or HER2 Positive metastatic breast cancer.
Therapeutic Effects of Hertab 250mg Tablet 150's
Hertab Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and Epidermal growth factor receptors (EGFRs) from signaling, which are produced by breast cancer cells. It kills cancer cells and slows down their growth.
Interaction of Hertab 250mg Tablet 150's with other drugs
Inform your doctor about any medicines you take or have taken before the treatment.
More Information about Hertab 250mg Tablet 150's
- Store below 30°C and away from light.
How to consume Hertab 250mg Tablet 150's
Take Hertab Tablet exactly as prescribed by your doctor. Take this medicine at least 1 hour before or after taking the food. Swallow the tablet and do not crush, open, or dissolve them.
Safety Advice for Hertab 250mg Tablet 150's
Breast Feeding
Hertab Tablet is unsafe during breastfeeding as this medication tends to pass into the breast milk and affect the baby.
Alcohol
Avoid drinking alcohol while taking this medication as it may cause dizziness.
Liver
Hertab tablets should be used with caution in patients with severe liver disease. Consult your physician for advice.
Lungs
Hertab tablets should be used with caution in patients with severe lung disease. Consult your physician for advice.
Driving
Hertab Tablet may affect your ability to drive or perform activities that require focus. Exercise caution while driving or using machines.
Pregnancy
It is not safe to consume Hertab tablets while you are pregnant. Consult your doctor and use a reliable contraception method to avoid becoming pregnant during this treatment.
Side Effects of Hertab 250mg Tablet 150's
Side effects are unwanted symptoms caused by medicines. Even though all medications cause side effects, not everyone gets them.
- Diarrhea (serious)
- Severe allergic reactions (serious)
- Skin rash (serious)
- Heart problems (serious)
- Loss of appetite
- Nausea, vomiting
- Tiredness, weakness
- Indigestion
- Constipation
- Sore mouth or mouth ulcers
- Stomach pain
- Trouble sleeping
- Back pain
- Pain in the hands and feet
- Joint or back pain
- Cough, breathlessness
- Headache
- Nose bleed
- Hot flush
- Unusual hair loss
- Dry skin and itching
Word of Advice
Hertab Tablet can cause severe diarrhea, so it is advised to take plenty of water during the treatment. Eat a well-balanced diet. Avoid consuming grapefruit juice while on treatment with Hertab Tablet as it affects how the medicine works. This medication makes your skin sensitive to the sun and increases the risk of skin rashes. Avoid spending more time in the sunlight, and ensure that you always apply sunscreen with a good SPF before stepping out. Wash your skin with a soap-free cleanser.
FAQs about Hertab 250mg Tablet 150's
Q1.
What is Hertab Tablet used for?
Hertab Tablet is used to treat advanced or HER2 Positive metastatic breast cancer.
Q2.
What is the most common side effect of Hertab Tablet?
The most common side effect of Hertab Tablet is Diarrhea. To prevent dehydration, consume lots of liquids, such as water or juice. If it is serious, consult your doctor right away.
Q3.
What is the mechanism of action of Hertab tablet?
Hertab Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and epidermal growth factor receptors (EGFRs) from signaling, which breast cancer cells produce. It kills cancer cells and slows down their growth.
Q4.
Is it safe to take Hertab Tablet while drinking juice?
No. Drinking grapefruit juice while taking Hertab Tablet can cause harmful interaction. Take this medicine with water only.
Q5.
Can a pregnant woman take Hertab Tablet?
No, Hertab Tablet is unsafe during pregnancy as it may harm the unborn baby. Therefore, it is advisable to tell your healthcare provider if you are pregnant or planning to have a baby before taking this medicine.
Q6.
Is Hertab Tablet safe for breastfeeding women?
Hertab Tablet is unsafe during breastfeeding as this medication passes into the breastmilk and affects the baby. It is not to be taken without the doctor's consent.
Fact Box of Hertab 250mg Tablet 150's
Molecule name: Lapatinib | Therapeutic class: Antineoplastic agent |
Pharmacological class: Kinase inhibitor | Indication: Advanced or HER2 Positive metastatic breast cancer |
References
- Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
- KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.
- Novartis Europharm Limited, Electronic medicines compendium (emc), [ Revised on March 2022] [ Accessed on 19th August 2022], https://www.medicines.org.uk/emc/files/pil.6292.pdf
- GlaxoSmithKline, US Food & Drug Administration, [ Accessed on 19th August 2022], https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022059s007lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Deva Prasath S.
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy